Tag Archives | Sanofi

Pharma Firm pays $25m to Resolve Corrupt Payments

The US Securities and Exchange Commission (SEC) announced that Paris-based pharmaceutical company Sanofi has agreed to pay more than $25 million to resolve charges that its Kazakhstan and the Middle East subsidiaries made corrupt payments to win business. According to the SEC’s order, the schemes spanned multiple countries and involved bribe payments to government procurement officials […]